HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jeffrey Kahl Selected Research

5- tert- butyl- N- cyclopropyl- 2- methoxy- 3- (2- (4- (2- morpholin- 4- ylethoxy)naphthalen- 1- yl)- 2- oxoacetylamino)benzamide

4/2010KR-003048, a potent, orally active inhibitor of p38 mitogen-activated protein kinase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jeffrey Kahl Research Topics

Disease

1Experimental Arthritis
04/2010
1Rheumatoid Arthritis
04/2010
1Edema (Dropsy)
04/2010
1Inflammation (Inflammations)
04/2010
1Chronic Obstructive Pulmonary Disease (COPD)
04/2010
1Osteoporosis
04/2010
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
04/2010
1Nausea
05/2006
1Pain (Aches)
05/2006

Drug/Important Bio-Agent (IBA)

2EnzymesIBA
04/2010 - 05/2006
1CarrageenanIBA
04/2010
15- tert- butyl- N- cyclopropyl- 2- methoxy- 3- (2- (4- (2- morpholin- 4- ylethoxy)naphthalen- 1- yl)- 2- oxoacetylamino)benzamideIBA
04/2010
1CytokinesIBA
04/2010
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2010

Therapy/Procedure

1Therapeutics
04/2010